2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | - | 23.798 | 76.585 | 148.831 | 181.291 | 164.486 | 172.873 | 139.773 | 140.871 | 139.274 |
Total Income - EUR | - | 24.135 | 78.265 | 148.833 | 183.789 | 166.511 | 172.864 | 139.809 | 140.873 | 139.282 |
Total Expenses - EUR | - | 29.558 | 75.283 | 136.293 | 168.088 | 160.924 | 160.830 | 150.078 | 145.911 | 145.650 |
Gross Profit/Loss - EUR | - | -5.423 | 2.982 | 12.540 | 15.701 | 5.587 | 12.034 | -10.269 | -5.038 | -6.368 |
Net Profit/Loss - EUR | - | -6.140 | 2.000 | 11.052 | 13.866 | 3.941 | 10.779 | -11.500 | -6.446 | -7.784 |
Employees | - | 3 | 2 | 3 | 3 | 3 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Pharma Klass Srl
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Check Financial Rating2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 215 | 367 | 518 | 685 | 1.217 | 1.817 | 2.461 | 3.038 | 2.210 | - |
Current Assets | - | 19.386 | 21.568 | 48.848 | 57.472 | 44.134 | 42.752 | 29.754 | 29.586 | 22.347 |
Inventories | - | 8.641 | 11.056 | 20.819 | 19.553 | 24.219 | 21.203 | 13.454 | 11.685 | 8.404 |
Receivables | - | 8.669 | 4.253 | 23.969 | 28.452 | 17.892 | 18.308 | 14.905 | 15.773 | 12.637 |
Cash | - | 2.076 | 6.259 | 4.059 | 9.467 | 2.023 | 3.242 | 1.394 | 2.127 | 1.306 |
Shareholders Funds | - | -6.095 | -4.033 | 7.087 | 20.823 | 24.361 | 34.678 | 22.410 | 16.033 | 8.200 |
Social Capital | - | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 |
Debts | - | 27.691 | 28.678 | 44.322 | 38.510 | 21.165 | 8.948 | 8.162 | 14.016 | 14.579 |
Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "4773 - 4773" | |||||||||
CAEN Financial Year | 4773 |
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Reports that can be accessed based on the subscription:
Get the contact details for any company and get in touch with it.